Affiliated to Jawaharlal Nehru Technological University Anantapur (JNTUA)
Accorded 2 (f) & 12 (B) status by UGC
NBA (UG) and NAAC Accredited Institution

Centre for Pharmaceutical Research (CPR)

Centre for Pharmaceutical Research

In view of developing Pharmaceutical Research in institution, RIPER constituted the “CENTRE FOR PHARMACEUTICAL RESEARCH” in the Research and Development cell (R & D Cell) to offer Research and Training facilities.

Constitution members of Centre for Pharmaceutical Research

S. No. Name Designation
1. Dr. Y. Padmanabha Reddy Chairman
2. Dr. J. Ravindra Reddy Co-Chairman
3. Dr. David Banji Research Director
4. Dr. P. Ramalingam Incharge for P.G.
5. Dr. P. Raghuveer Varma Research Co-Ordinate


Department of Pharmaceutical Analysis & Quality Assurance

  1. Analytical Quality by Design (AQbD) in analytical method development by HPLC Stability indicating assay and impurity characterization by HPLC / Flash LC.
  2. Development of Stability indicating assays for single / Multi-component Dosage forms
  3. Identification, purification and Characterization of degradation Products from APIs.
  4. Simultaneous estimation of dosage forms of new arrivals in the market under ANDA / NDA.
  5. Method development and validation by GC-FID.
  6. Development of Finger prints for Herbal Drugs / formulations.
  7. Standardization of Crude drugs as per WHO guidelines.
  8. RP-HPLC method development and validation.
  9. Stability studies for formulations and bulk products.
  10. Training on HPLC trouble shooting.
  11. Method development and validation in UV-Visible spectrophotometer.
  12. Qualitative and quantitative analysis of FT-IR.
  13. Training on FT-IR Spectrophotometer (Pellet technique, liquid cell, ATR, DRS).
  14. Training on Karl fischer titrimetric method.

Currently the Dept. of Pharmaceutical Analysis & Quality Assurance carry out the following for commercial samples:

  • Method development and validation of HPLC/ UV/ Colorimetry/ FT-IR Quantification
  • Stress studies
  • Bioanalysis
  • Bio-equivalence studies
  • FT-IR Spectral analysis for polymorphism, identification, drug–excipient interactions

Department of Pharmaceutics

  1. Quality by Design (QbD) and DoE in formulation development.
  2. Implementation of Control release technology in new dosage forms.
  3. Dissolution rate enhancement Technology.
  4. Vesicular and micro-particulate systems.
  5. Development Newer Excipients / additives/ Polymers from Natural Resources.

Department of Pharmacology – Medicinal Chemistry (Inter-disciplinary)

  1. Isolation of Phyto-constituents, Characterization and Biological evaluation.
  2. Synthesis/semi-synthetic analogues and their Pharmacological evaluation/ Chemotherapeutic potentials.
  3. Neuro-pharmacological Screenings.
  4. Immunomodulation Studies.
  5. Histopathological and Toxicity studies.
  6. Screening of new entities for endocrinological and all metabolic disorders.